Compare Stocks: IPCX, ZVIA, RKDA, and KO

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
IPCX Inflection Point Acquisition Corp. III	$3.95 +3.7%	$9.08	$3.75 ▼ $11.50	$131.34M	0.2	102,922 shs	154,821 shs
KO CocaCola	$87.66 +0.3%	$83.51	$65.35 ▼ $90.92	$376.13B	0.33	17.04 million shs	9.16 million shs
RKDA Arcadia Biosciences	$0.62 +9.6%	$0.72	$0.50 ▼ $6.71	$1.37M	0.56	156,549 shs	139,968 shs
ZVIA Zevia PBC	$1.33 +1.9%	$1.56	$1.11 ▼ $3.22	$100.08M	0.99	402,452 shs	679,141 shs

10 Best Stocks to Own - Summer 2026

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
IPCX Inflection Point Acquisition Corp. III	-7.07%	-18.06%	-63.33%	-63.01%	+380,999,900.00%
KO CocaCola	+0.91%	+1.00%	+5.31%	+8.29%	+24.28%
RKDA Arcadia Biosciences	-18.59%	-20.34%	-8.08%	-40.36%	-87.50%
ZVIA Zevia PBC	-4.65%	-12.41%	-25.53%	-2.56%	-56.64%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
IPCX Inflection Point Acquisition Corp. III	$3.95 +3.7%	$9.08	$3.75 ▼ $11.50	$131.34M	0.2	102,922 shs	154,821 shs
KO CocaCola	$87.66 +0.3%	$83.51	$65.35 ▼ $90.92	$376.13B	0.33	17.04 million shs	9.16 million shs
RKDA Arcadia Biosciences	$0.62 +9.6%	$0.72	$0.50 ▼ $6.71	$1.37M	0.56	156,549 shs	139,968 shs
ZVIA Zevia PBC	$1.33 +1.9%	$1.56	$1.11 ▼ $3.22	$100.08M	0.99	402,452 shs	679,141 shs

10 Best Stocks to Own - Summer 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
IPCX Inflection Point Acquisition Corp. III	-7.07%	-18.06%	-63.33%	-63.01%	+380,999,900.00%
KO CocaCola	+0.91%	+1.00%	+5.31%	+8.29%	+24.28%
RKDA Arcadia Biosciences	-18.59%	-20.34%	-8.08%	-40.36%	-87.50%
ZVIA Zevia PBC	-4.65%	-12.41%	-25.53%	-2.56%	-56.64%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
IPCX Inflection Point Acquisition Corp. III	2.00	Hold	$12.00	203.80% Upside
KO CocaCola	2.83	Moderate Buy	$95.76	9.25% Upside
RKDA Arcadia Biosciences	1.00	Sell	N/A	N/A
ZVIA Zevia PBC	2.25	Hold	$4.50	239.62% Upside

Current Analyst Ratings Breakdown

Latest IPCX, ZVIA, RKDA, and KO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/31/2026	KO CocaCola	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy (B+)
7/30/2026	KO CocaCola	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$91.00 ➝ $93.00
7/30/2026	KO CocaCola	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$91.00 ➝ $97.00
7/29/2026	KO CocaCola	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$87.00 ➝ $96.00
7/29/2026	KO CocaCola	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target	Buy	$98.00 ➝ $104.00
7/29/2026	KO CocaCola	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$88.00 ➝ $95.00
7/29/2026	KO CocaCola	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$90.00 ➝ $95.00
7/29/2026	KO CocaCola	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Market Perform	$93.00
7/29/2026	KO CocaCola	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$89.00 ➝ $100.00
7/29/2026	KO CocaCola	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$97.00 ➝ $100.00
7/21/2026	IPCX Inflection Point Acquisition Corp. III	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Speculative Buy	$12.00

(Data available from 8/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
IPCX Inflection Point Acquisition Corp. III	N/A	N/A	N/A	N/A	N/A	N/A
KO CocaCola	$47.94B	7.87	$3.27 per share	26.83	$8.91 per share	9.84
RKDA Arcadia Biosciences	$4.86M	0.31	$1.42 per share	0.44	$2.39 per share	0.26
ZVIA Zevia PBC	$161.26M	0.63	N/A	N/A	$0.43 per share	3.08

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
IPCX Inflection Point Acquisition Corp. III	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
KO CocaCola	$13.11B	$3.33	26.32	24.90	3.05	28.56%	39.38%	13.18%	10/20/2026 (Estimated)
RKDA Arcadia Biosciences	-$2.34M	-$4.56	N/A	N/A	N/A	-234.53%	-144.61%	-88.15%	N/A
ZVIA Zevia PBC	-$9.92M	-$0.13	N/A	N/A	N/A	-5.34%	-16.92%	-9.56%	N/A

Latest IPCX, ZVIA, RKDA, and KO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2026	Q2 2026	IPCX Inflection Point Acquisition Corp. III	N/A	$0.08	N/A	$0.08	N/A	N/A
8/13/2026	Q2 2026	RKDA Arcadia Biosciences	-$0.56	-$0.38	+$0.18	-$2.09	$1.90 million	$1.44 million
8/5/2026	Q2 2026	ZVIA Zevia PBC	-$0.03	-$0.03	N/A	-$0.04	$44.21 million	$45.00 million
7/28/2026	Q2 2026	KO CocaCola	$0.9320	$0.97	+$0.0380	$1.03	$13.17 billion	$13.37 billion
5/14/2026	Q1 2026	IPCX Inflection Point Acquisition Corp. III	N/A	$0.07	N/A	$0.07	N/A	N/A
5/14/2026	Q1 2026	RKDA Arcadia Biosciences	-$0.80	-$2.11	-$1.31	-$2.11	$1.60 million	$1.10 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
IPCX Inflection Point Acquisition Corp. III	N/A	N/A	N/A	N/A	N/A
KO CocaCola	$2.12	2.42%	+4.46%	63.66%	64 Years
RKDA Arcadia Biosciences	N/A	N/A	N/A	N/A	N/A
ZVIA Zevia PBC	N/A	N/A	N/A	N/A	N/A

Latest IPCX, ZVIA, RKDA, and KO Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/15/2026	KO CocaCola	quarterly	$0.53	2.57%	9/15/2026	9/15/2026	10/1/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
IPCX Inflection Point Acquisition Corp. III	N/A	N/A	N/A
KO CocaCola	0.97	1.30	1.12
RKDA Arcadia Biosciences	N/A	3.79	3.17
ZVIA Zevia PBC	N/A	1.90	1.33

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
IPCX Inflection Point Acquisition Corp. III	N/A
KO CocaCola	70.26%
RKDA Arcadia Biosciences	17.73%
ZVIA Zevia PBC	53.21%

Insider Ownership

Company	Insider Ownership
IPCX Inflection Point Acquisition Corp. III	N/A
KO CocaCola	0.90%
RKDA Arcadia Biosciences	8.20%
ZVIA Zevia PBC	7.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
IPCX Inflection Point Acquisition Corp. III	3	34.47 million	N/A	N/A
KO CocaCola	65,900	4.30 billion	4.26 billion	Optionable
RKDA Arcadia Biosciences	60	2.41 million	2.21 million	Not Optionable
ZVIA Zevia PBC	130	76.98 million	71.06 million	Optionable

IPCX, ZVIA, RKDA, and KO Headlines

Recent News About These Companies

Zevia Statement Regarding Kanen Wealth Management LLC

August 14 at 4:09 PM | businesswire.com

Activist investor calls for strategic review at Zevia

August 14 at 8:09 AM | seekingalpha.com

Kanen Wealth Management calls for sale of Zevia to Maximize shareholder value

August 14 at 7:00 AM | globenewswire.com

Zevia PBC Q2 Earnings Call Highlights

August 9, 2026 | marketbeat.com

Zevia: The Fanbase Nobody Can Find

August 9, 2026 | seekingalpha.com

Zevia PBC (NYSE:ZVIA) Lowered to "Sell" Rating by Wall Street Zen

August 8, 2026 | americanbankingnews.com

Zevia PBC (NYSE:ZVIA) Rating Lowered to Sell at Wall Street Zen

August 8, 2026 | marketbeat.com

Zevia Earnings Call Balances Growth Hopes And Headwinds

August 6, 2026 | tipranks.com

Zevia PBC (ZVIA) Q2 2026 Earnings Call Transcript

August 6, 2026 | seekingalpha.com

Zevia PBC (NYSE:ZVIA) Receives Consensus Rating of "Hold" from Analysts

August 6, 2026 | marketbeat.com

Zevia (ZVIA) Reports Q2 Loss, Beats Revenue Estimates

August 5, 2026 | zacks.com

Zevia PBC (NYSE:ZVIA) Issues Earnings Results

August 5, 2026 | marketbeat.com

Zevia Announces Second Quarter 2026 Results

August 5, 2026 | businesswire.com

Zevia PBC (ZVIA) to Release Earnings on Wednesday

July 29, 2026 | marketbeat.com

Kanen Wealth Management LLC Purchases New Position in Zevia PBC $ZVIA

July 29, 2026 | marketbeat.com

Stoic Point Capital Management LLC Makes New $867,000 Investment in Zevia PBC $ZVIA

July 29, 2026 | marketbeat.com

Zevia (ZVIA) Illustrates the Strategy’s Sell Discipline

July 24, 2026 | insidermonkey.com

Zevia to Announce Second Quarter 2026 Earnings Results on August 5, 2026

July 22, 2026 | businesswire.com

ZEVIA AND CARDI B LAUNCH "REAL TALK INTERPRETER" CAMPAIGN

July 21, 2026 | finance.yahoo.com

Analysts’ Opinions Are Mixed on These Consumer Goods Stocks: The Andersons (ANDE), Zevia PBC (ZVIA) and Target (TGT)

June 20, 2026 | theglobeandmail.com

Zevia Shareholders Back Board Nominees and Auditor Choice

June 15, 2026 | tipranks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

IPCX, ZVIA, RKDA, and KO Company Descriptions

Inflection Point Acquisition Corp. III NASDAQ:IPCX

$3.95 +0.14 (+3.67%)

Closing price 04:00 PM Eastern

Extended Trading

$4.23 +0.28 (+6.99%)

As of 07:56 PM Eastern

We are a special purpose acquisition company incorporated on January 31, 2024, as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. However, members of our management team had been actively in discussions with potential business combination partners in their capacity as officers and directors of Inflection Point Acquisition Corp. II (“IPXX”), and we may pursue business combination partners that had previously been in discussions with IPXX’s management team. While we may pursue an initial business combination in any industry, sector or geographic region, we intend to focus our search initially on North American and European businesses in disruptive growth sectors, which complements the expertise of our management team. Our company will combine the abilities of a diverse and founder-friendly management team. We have assembled a management team with experience across both public and private markets with deep roots in our target markets. Our team combines decades of experience sourcing, researching, and investing in complex transactions that create value for shareholders. We expect to seek an investment opportunity where each member of our management team can leverage their expertise and network to create significant value. We will seek fundamentally strong businesses in a broad range of disruptive growth sectors, with emphasis on one or more of the following attributes, although we may decide to enter into a business combination with a target business that does not have one or more of these attributes: • Innovative, technology-enabled company of scale focused on acquiring new customers with a large addressable market, legacy analogue competitors and a differentiated path to market or superior product. • Customer focused and deeply experienced team fueled by a shared connection and passion for the business. • Operates in an industry not typically active in traditional IPOs, but that our management feels public market investors will value and desire exposure to the public market. • Achieved a scale such that the profit contribution from existing business offsets fixed costs and is prepared to reinvest in high return on capital opportunities. • Adaptable to the rapidly changing business environment and major shift in demographics with the ability generate shareholder value in any market cycle. Our executive offices are located in New York, New York.

CocaCola NYSE:KO

$87.66 +0.24 (+0.27%)

Closing price 03:59 PM Eastern

Extended Trading

$87.75 +0.09 (+0.10%)

As of 07:59 PM Eastern

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, caffeine free Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.

Arcadia Biosciences NASDAQ:RKDA

$0.62 +0.05 (+9.60%)

As of 04:00 PM Eastern

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

Zevia PBC NYSE:ZVIA

$1.32 +0.03 (+1.92%)

Closing price 03:59 PM Eastern

Extended Trading

$1.36 +0.03 (+2.26%)

As of 07:58 PM Eastern

Zevia PBC, a beverage company, develops, markets, sells, and distributes various carbonated beverages in the United States and Canada. It offers soda, energy drinks, organic tea, and kidz drinks. The company offers its products through a network of food, drug, warehouse club, mass, natural, convenience, and e-commerce channels, as well as grocery distributors and natural product stores and specialty outlets. It provides its products under the Zevia brand name. The company was founded in 2007 and is headquartered in Encino, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest IPCX, ZVIA, RKDA, and KO Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest IPCX, ZVIA, RKDA, and KO Earnings

Compare Dividends

Latest IPCX, ZVIA, RKDA, and KO Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

IPCX, ZVIA, RKDA, and KO Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

IPCX, ZVIA, RKDA, and KO Company Descriptions

Inflection Point Acquisition Corp. III NASDAQ:IPCX

CocaCola NYSE:KO

Arcadia Biosciences NASDAQ:RKDA

Zevia PBC NYSE:ZVIA

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools